Parenteral Drugs (India) Limited (PDPL) Financial Statements

0 Followers

Parenteral Drugs (India) Limited Financial Overview

Parenteral Drugs (India) Limited's market cap is currently ₹101.08M. The company's EPS TTM is $; its P/E ratio is ―; Parenteral Drugs (India) Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 22	Mar 21	Mar 20	Mar 19	Mar 17
Income Statement
Total Revenue	₹ 84.96M	₹ 121.53M	₹ 240.25M	₹ 319.98M	₹ 2.30B
Gross Profit	₹ 30.31M	₹ 48.37M	₹ 13.40M	₹ 75.64M	₹ 519.82M
Operating Income	₹ -117.56K	₹ -82.97K	₹ -320.32K	₹ -867.78K	₹ -1.28B
EBITDA	₹ 372.69M	₹ -117.09M	₹ -144.39M	₹ -162.40M	₹ -179.85M
Net Income	₹ -763.62M	₹ -1.22B	₹ -1.14B	₹ -1.48B	₹ -1.15B
Balance Sheet
Cash & Short-Term Investments	₹ 1.00K	₹ 569.89K	₹ 1.08M	₹ 953.02K	₹ 3.61M
Total Assets	₹ 4.84B	₹ 5.68B	₹ 5.52B	₹ 5.41B	₹ 10.19B
Total Debt	₹ 1.07B	₹ 10.72B	₹ 9.46B	₹ 8.40B	₹ 6.49B
Net Debt	₹ 1.07B	₹ 10.72B	₹ 9.46B	₹ 8.40B	₹ 6.49B
Total Liabilities	₹ 13.08B	₹ 12.51B	₹ 11.13B	₹ 9.87B	₹ 8.08B
Stockholders' Equity	₹ -8.24B	₹ -6.83B	₹ -5.61B	₹ -4.47B	₹ 2.10B
Cash Flow
Free Cash Flow	₹ -4.83M	₹ 1.25B	₹ 1.12B	₹ 4.77B	₹ 537.15M
Operating Cash Flow	₹ -4.83M	₹ 1.25B	₹ 1.12B	₹ 4.77B	₹ 541.42M
Investing Cash Flow	₹ 647.25M	₹ 618.56K	₹ 789.25K	₹ 965.77M	₹ -4.28M
Financing Cash Flow	₹ -642.99M	₹ -1.25B	₹ -1.12B	₹ -5.74B	₹ -550.56M

Currency in INR

Parenteral Drugs (India) Limited Earnings and Revenue History

Income Statement >

Parenteral Drugs (India) Limited Debt to Assets

Balance Sheet >

Parenteral Drugs (India) Limited Cash Flow

Cash Flow >

Parenteral Drugs (India) Limited Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >